Managing menopausal symptoms after cancer: an evidence‐based approach for primary care-Reference-Cited by-同舟云学术

Managing menopausal symptoms after cancer: an evidence‐based approach for primary care

Published:2018-02 Issue:3 Volume:208 Page:127-132
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Marino Jennifer L¹²,McNamara Helen C¹,Hickey Martha¹²

Affiliation:

1. Royal Women's Hospital, Melbourne, VIC

2. University of Melbourne, Melbourne, VIC

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja17.00693

Reference76 articles.

1. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study

2. Non‐hormonal treatments for menopausal symptoms;Hickey M;BMJ,2017

3. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters

4. Australian Institute of Health and Welfare.Cancer in Australia 2017 (AIHW Cat. No. CAN 100; Cancer Series No. 101). Canberra: AIHW;2017.https://www.aihw.gov.au/getmedia/3da1f3c2‐30f0‐4475‐8aed‐1f19f8e16d48/20066‐cancer‐2017.pdf.aspx?inline=true(viewed Dec 2017).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Priorities for alleviating menopausal symptoms after cancer;Menopause;2022-11-20

2. Barriers to surgical menopause counseling in gynecologic cancers: a quantitative and qualitative study of patients and providers;Menopause;2022-08

3. Efficacy of interventions to manage sexual dysfunction in women with cancer: a systematic review;Menopause;2022-05

4. The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study;Contemporary Clinical Trials Communications;2021-12

5. The risk of menopausal symptoms in premenopausal breast cancer patients and current pharmacological prevention strategies;Expert Opinion on Drug Safety;2021-05-17